Here's what Benzinga's reading on our friend, TheStreet.com.
What's Hot On TheStreet
NFL Lockout Ends; Blackouts Won't Both the NFL's players and its owners are likely very happy to have the five- month mess behind them and their revenue streams intact. League partners including Papa John's PZZA , Anheuser-Busch InBev BUD and PepsiCo PEP are also sweating a little less now that their nine-figure marketing investments are out of danger, and DirectTV DTV is very happy that its "You Won't Pay Until They Play" strategy for its $335-a-season NFL Sunday Ticket package never had to be deployed.
Smartphone Owners Not That Into Phone Calls Maybe their Apple AAPL iPhones keep dropping calls because smartphone owners aren't really fans of actual phone calls.
5 Must-Haves for Your Small Office It's 2011. Do you still need a fax machine in your office at home or in the back of your store?
Top Drug Stocks Brace for Big Patent Losses While second-quarter results at the three biggest U.S. drugmakers are expected to be strong, investors might need to take a sedative to prepare for the potential drop in revenue that will happen as patents on money-making medications expire.
Market News and Data brought to you by Benzinga APIsWhat's Hot On TheStreet
NFL Lockout Ends; Blackouts Won't Both the NFL's players and its owners are likely very happy to have the five- month mess behind them and their revenue streams intact. League partners including Papa John's PZZA , Anheuser-Busch InBev BUD and PepsiCo PEP are also sweating a little less now that their nine-figure marketing investments are out of danger, and DirectTV DTV is very happy that its "You Won't Pay Until They Play" strategy for its $335-a-season NFL Sunday Ticket package never had to be deployed.
Smartphone Owners Not That Into Phone Calls Maybe their Apple AAPL iPhones keep dropping calls because smartphone owners aren't really fans of actual phone calls.
5 Must-Haves for Your Small Office It's 2011. Do you still need a fax machine in your office at home or in the back of your store?
Top Drug Stocks Brace for Big Patent Losses While second-quarter results at the three biggest U.S. drugmakers are expected to be strong, investors might need to take a sedative to prepare for the potential drop in revenue that will happen as patents on money-making medications expire.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsBroadcasting & Cable TVComputer HardwareConsumer DiscretionaryConsumer StaplesInformation TechnologyRestaurantsSoft Drinks
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in